Enzalutamide Capsules are androgen receptor inhibitors used in the treatment of certain forms of prostate cancer. Enzalutamide works by blocking androgen receptor signaling, which reduces the ability of male hormones such as testosterone to stimulate the growth of prostate cancer cells.

What are Enzalutamide Capsules?

Enzalutamide is the active ingredient in Xtandi. It is an androgen receptor inhibitor (antiandrogen) that interferes with androgen signaling involved in prostate cancer progression.

• Drug Classification: Androgen Receptor Inhibitor / Antiandrogen
• Therapeutic Use: Antineoplastic / Prostate Cancer
• Route of Administration: Oral
• Active Ingredient: Enzalutamide

Benefits of Enzalutamide Capsules

• Advanced Prostate Cancer: Used to treat certain advanced forms of prostate cancer.
• Metastatic Prostate Cancer: Used when prostate cancer has spread to other parts of the body.
• Castration-Resistant Prostate Cancer: May be used when prostate cancer progresses despite androgen-deprivation therapy.
• Androgen Receptor Inhibition: Blocks hormonal signaling that can promote prostate cancer cell growth.

Dosage Guidelines

The dosage of Enzalutamide is determined by an oncologist based on the patient’s cancer type and stage, previous treatment, overall health, and other medicines.

Enzalutamide is generally administered orally once daily, with or without food, according to the prescribed treatment plan. Patients should not change the dose or stop treatment without consulting their healthcare professional.

Enzalutamide Capsules Wholesale & Supply

Onco India International provides wholesale and bulk pharmaceutical supply of Enzalutamide products to eligible pharmacies, hospitals, healthcare providers, distributors, and other authorized buyers, subject to applicable regulations.

Buying Enzalutamide Capsules Online

Enzalutamide is a prescription oncology medicine and should be obtained through authorized pharmaceutical suppliers. Buyers should verify product authenticity, strength, manufacturer information, packaging, expiry date, and applicable regulatory requirements.

Reviews on Enzalutamide Capsules

Patients receiving Enzalutamide may experience benefits in the management of advanced prostate cancer. Individual treatment responses vary according to the stage of cancer, previous treatment, overall health, and response to therapy.

Patient reviews should not replace advice from a qualified oncologist.

Quality Assurance

Enzalutamide products supplied by Onco India International are intended to meet applicable pharmaceutical quality and regulatory requirements. Proper manufacturing, storage, packaging, and distribution practices are important for maintaining product quality.

Patients should inform their healthcare professional about all medicines and supplements they are taking because Enzalutamide can interact with certain medicines.

Frequently Asked Questions

1. What is Xtandi used for?
Xtandi contains Enzalutamide and is used to treat certain forms of advanced prostate cancer.

2. How does Enzalutamide work?
Enzalutamide blocks androgen receptor signaling, reducing the effect of male hormones that can stimulate prostate cancer cell growth.

3. Is Enzalutamide a chemotherapy medicine?
Enzalutamide is not a traditional cytotoxic chemotherapy drug. It is an androgen receptor inhibitor used as hormone-based cancer therapy.

4. How is Enzalutamide taken?
Enzalutamide is taken orally, generally once daily, according to the dosage prescribed by the treating oncologist.

5. What are common side effects of Enzalutamide?
Common side effects may include fatigue, hot flushes, headache, dizziness, and increased blood pressure. Other serious adverse effects may occur and require medical attention.

6. Can Enzalutamide interact with other medicines?
Yes. Enzalutamide can affect the metabolism of several medicines. Patients should inform their healthcare professional about all medicines and supplements they are taking.

Conclusion

Onco India International supplies and exports Enzalutamide Capsules (Xtandi) for pharmaceutical and oncology requirements, subject to applicable regulatory requirements. Enzalutamide is an androgen receptor inhibitor used in the treatment of certain advanced prostate cancers.

For safe and effective treatment, Enzalutamide should be used only under the supervision of a qualified oncologist, with the appropriate dose and treatment duration determined according to the patient’s condition.